Identification, Validation & Use of Biomarkers to Accelerate Therapeutic Evaluation in Neurodevelopmental Disorders
Time: 4:00 pm
day: Day One
• Pushing the development of translational and quantitative biomarkers to augment outcomes measures
• Developing new strategies to restore cortical function and critical period timing by targeting Excitatory/Inhibitory circuits as a possible therapeutic intervention.
• What biomarkers can be broadly applicable across neurodevelopmental disorders? Which ones are disease specific?
• Can we develop a portfolio of biomarkers that complement one another to choose for your clinical trial?